Kisspeptin describes a family of peptides encoded by the KISS1 gene and signaling through the KISS1 receptor (formerly GPR54); the principal mature human product, kisspeptin-54 (KP-54, historically called metastin), undergoes proteolytic cleavage into shorter active fragments such as KP-14, KP-13 and KP-10, all sharing the C-terminal RF-amide core recognized by KISS1R (IUPHAR kisspeptin receptor review, […]
Monthly Archives: November 2026
A GLP-1 peptide in a 5 mg vial is a lyophilized research reagent belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist family — synthetic analogs designed for receptor signaling, binding and analytical studies — where the “5 mg” refers to nominal peptide mass per vial, not a pre-made solution concentration. Because GLP-1 analogs differ in […]
Adipotide, also abbreviated FTPP (fat-targeted proapoptotic peptide), is a synthetic chimeric peptidomimetic that combines a white-adipose-tissue vascular homing motif with a pro-apoptotic effector sequence; in published preclinical work it was designed to bind endothelial cells lining fat vasculature and trigger local programmed cell death, making it a model molecule for vascular-targeted peptide research rather than […]
PT-141 (bremelanotide) is a synthetic cyclic melanocortin peptide from the alpha-MSH family that engages central melanocortin receptors, predominantly MC4R with MC3R contributions, within hypothalamic and limbic circuits linked to sexual desire. Unlike vascular erectile pharmacology, its pathway targets central arousal processing rather than penile blood flow, making it a distinct research probe. Bremelanotide exists both […]
Melanotan 2 acetate (MT-2, MT-II) is a synthetic cyclic heptapeptide analog of alpha-MSH that acts as an agonist across melanocortin receptors, including pigmentation-linked MC1R and central MC3R/MC4R sites. Its lactam-bridged cyclic scaffold improves metabolic stability versus linear peptides; it arose from 1990s University of Arizona research exploring photoprotection. Because MT-2 engages several receptor subtypes, published […]
What Is the BPC-157 10 mg + TB-500 10 mg Configuration? The BPC-157 10 mg + TB-500 10 mg configuration is the higher specification of the store’s variable “BPC + TB” research kit: a 10 mg BPC-157 vial paired with a 10 mg TB-500 vial per paired set (20 mg total peptide mass per pair), […]
What Is the BPC-157 5 mg + TB-500 5 mg Combo? The BPC-157 5 mg + TB-500 5 mg combination (marketed in the store as “BPC + TB”) is a research kit that pairs two synthetic repair-associated peptides in matched vials: BPC-157, a 15-amino-acid pentadecapeptide studied for angiogenic and cytoprotective signaling, and TB-500, the synthetic […]
Melanotan 1 (MT-1, afamelanotide) is a synthetic linear tridecapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that preferentially activates melanocortin 1 receptor (MC1R) on melanocytes to support eumelanin production. It emerged from 1980s University of Arizona research as a stable, receptor-selective ligand than cyclic analogs. In published pharmacology, MT-1 engages the Gs-cAMP pathway upstream of MITF and […]
What Is BPC-157? BPC-157 (body protection compound 157) is a synthetic 15-amino-acid pentadecapeptide derived from a fragment of a protein isolated from human gastric juice; its reported sequence is GEPPPGKPADDAGLV (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) and its average molecular weight is approximately 1,419 Da. It was developed for laboratory research purposes, principally as an investigational tool for studying tissue […]
Retatrutide (development code LY3437943) is an investigational acylated peptide agonist investigated in endocrine research for activity at GIP, GLP-1 and glucagon receptors; this guide deliberately stays on the product-decision side of procurement — reference identity, catalog vial formats, purity documentation, lot-level quality control and a side-by-side buying comparison with semaglutide and tirzepatide. It does not […]
